In summary, this study reveals that the administration of HNK and cetuximab, as a therapeutic potential combination, shows better anti-cancer effects in vitro and vivo. Honokiol disrupted SNX3 retromer function, induced the inhibition of autophagy and macropinoctosis fluxes, along with the inhibitory effect in EGFR signaling pathway. This evidence concerns the gene SNX3 and cancer.